Leaders' Update 
A message from Charles Geyer, M.D., F.A.C.P., associate director for clinical research
Massey has a rich history of innovative and vibrant clinical research, developed and conducted by superb basic and clinical scientists supported by an outstanding clinical research staff and the remarkable philanthropic generosity of Massey supporters.
This message continues with information about:
|
Signaling pathway could impact a variety of autoinflammatory diseases
New findings offer insight into the role that activation of interferon-regulatory factor 1 (IRF1), a protein that functions as a transcriptional activator of a variety of target genes, plays in the production of chemokines and the recruitment of mononuclear cells to sites of sterile inflammation.
|
Holding the promise to improved health care
A new article recommends changes to electronic health record functionality in order to better support the needs of primary care and patient-centered care.
|
Andrew Poklepovic to present at TEDxRVA
Andrew Poklepovic, M.D., will be presenting at this year's TEDxRVA event on "Redefining the War on Cancer." He will discuss targeted therapies and next generation immunotherapies.
|
Member Showcase
Hartman works to develop new cancer-fighting drugs and target therapies
Matthew Hartman, Ph.D., member of the Developmental Therapeutics program, focuses his research on developing drugs that inhibit key cancer proteins and developing better ways to target cancer tumors by studying how proteins interact with each other on the molecular level.
|
Grant to play key role at prestigious internal cancer research conference
Steven Grant, M.D., was recently selected to serve as chairperson of the Small Molecule Therapeutic Agents Section of the Molecular Therapeutics Subcommittee of the Program Committee for the American Association of Cancer Research (AACR) 2014 Annual Meeting.
|
Wang awarded NCI grant to study tumor recurrence after radiation therapy
Xiang-Yang (Shawn) Wang, Ph.D., was recently awarded a $316,438 grant from the National Cancer Institute to support his studies on tumor recurrence after radiation therapy.
|
Massey Members External Collaboration Survery
Massey needs your help in collecting information on members' research collaborations with external partners/institutions. This information is important in demonstrating the breadth of research collaborations at the Center.
Please fill out this form to provide information on your 2013 and ongoing external collaborations.
|
